Details

Last Funding Type

Grant

Last Funding Money Raised

$1.70M

Industries

Biotechnology,Health Care,Medical Device

Founded date

Oct 1, 2015

Number Of Employee

1 - 10

Operating Status

Active

ETI have developed a patented, unique medical device that removes galectin-3 from human blood. The device removes both bound and free galectin-3 from the circulation, offering a new treatment option that is less invasive and has fewer side-effects than other therapies. The single-use apheresis column selectively removes Galectin-3 from the body. It contains a proprietary, highly effective capturing molecule and is built in a format that hospitals already know how to use.